
Cutting is not weight loss. Weight loss is about the scale; cutting is about fat-to-lean ratio. A lifter going from 18% body fat to 10% who drops 15 lb needs 13 of those pounds to be fat — not 10 fat and 5 muscle, which is what a naive GLP-1 cycle produces.
This article ranks the peptides that actually cut — meaning they either target fat tissue specifically, preserve lean mass through GH/IGF-1 elevation, or stack with a GLP-1 to shift the body-composition ratio. The top picks are the GH peptide stacks (tesa+ipa, CJC+ipa), with cagrilintide as the best pure-weight-loss addition and AOD-9604 as a niche adjunct.
If you are a lifter cutting for aesthetics or a weight class, this is the ranking. If you are on a medical GLP-1 for obesity treatment, see Preserve Muscle on Semaglutide & Tirzepatide.
What Makes a Good Cutting Peptide
Three criteria:
- Mechanism preserves lean mass. GH/IGF-1 elevation, amylin signaling, or direct lipolytic effect — not pure appetite suppression.
- Clinical evidence for body composition, not just weight. Trials must report DXA-measured fat and lean mass separately.
- Practical in a cycle of 12-16 weeks. Side effect profile manageable, bloodwork cadence reasonable, cost per cycle under $600 for the base stack.
Quick Comparison Table
The Ranking
1. Tesamorelin + Ipamorelin (Blend)
The strongest cutting stack on evidence. Tesamorelin has the deepest clinical data of any GHRH analog — phase III RCT at 26 weeks showed 15-18% visceral fat reduction plus an 80% IGF-1 increase versus placebo. A secondary analysis confirmed decreased intramuscular fat and increased muscle cross-sectional area — the exact body-composition profile a cut is chasing.
Paired with ipamorelin — the selective GHRP with no cortisol or prolactin spike (Raun et al., 1998) — the stack produces a GH pulse 2-3x larger than either alone (Bowers et al., 1990). The clean GHRP profile matters on a cut: GHRP-2 or GHRP-6 bump cortisol and appetite, which is counterproductive when you are trying to stay in a deficit.
Cutting protocol: 2 mg tesamorelin + 100-200 mcg ipamorelin, subcutaneous, 5 days per week, pre-bed fasted. Run 12-16 weeks.
Deep dive: Best Tesamorelin + Ipamorelin Vendors | Tesamorelin Dosing Guide
Top Tesamorelin + Ipamorelin Vendors
Ranked by price, COA availability, and reputation
2. CJC-1295 + Ipamorelin (Blend)
The cheaper, more widely stocked alternative. Same GHRH+GHRP mechanism, different GHRH molecule. CJC-1295 (no DAC) has a ~30-minute effective half-life — long enough to amplify the ipamorelin pulse, short enough to preserve natural GH rhythm (Teichman et al., 2006).
For a cut, the trade-off vs tesa+ipa is straightforward: tesamorelin has more direct RCT evidence for body-composition endpoints; CJC-1295 has more PK/PD data and costs roughly half as much per cycle. If this is your first cutting stack or budget matters, this is the pick.
Cutting protocol: 100 mcg CJC-1295 + 100 mcg ipamorelin, pre-bed fasted. Experienced users run 2-3 doses per day (pre-workout, pre-bed, or AM fasted).
Deep dive: Best CJC-1295 + Ipamorelin Vendors
Top CJC-1295 + Ipamorelin Vendors
Ranked by price, COA availability, and reputation
3. Cagrilintide (+ Semaglutide)
The cutting add-on when fat loss stalls on a GHRH+GHRP alone, or the base weight-loss driver for users coming from a GLP-1 background. Cagrilintide is a long-acting amylin analog; amylin signals satiety through a pathway distinct from GLP-1 and preserves lean mass better than pure GLP-1 agonism in body-composition analyses.
The REDEFINE 1 trial of cagrilintide + semaglutide produced 20.4% body weight loss at 68 weeks, with a favorable fat-to-lean ratio. For a lifter, the cagrilintide half of the stack is the muscle-preservation advantage over running semaglutide alone.
Cutting protocol: Escalate cagrilintide 0.25 mg → 2.4 mg weekly over 16 weeks, paired with semaglutide 2.4 mg weekly. Run alongside tesa+ipa or CJC+ipa for the anabolic support layer.
Deep dive: Best Cagrilintide Vendors | Cagrilintide vs Semaglutide
Top Cagrilintide Vendors
Ranked by price, COA availability, and reputation

4. Tesamorelin (Solo)
Running tesamorelin without a paired GHRP leaves half the synergy on the table — but solo tesamorelin still produces the visceral fat reduction its phase III trials are famous for. If you already have a GHRP you prefer, or if vial consolidation is the issue, tesamorelin alone is a reasonable cutting tool.
Cutting protocol: 2 mg tesamorelin daily, subcutaneous, AM fasted or pre-bed. 12-16 weeks.
Deep dive: Best Tesamorelin Vendors | Tesamorelin Results Timeline
Top Tesamorelin Vendors
Ranked by price, COA availability, and reputation
5. MK-677 (Oral)
The no-needle option for cutting. MK-677 activates the ghrelin receptor orally and raises GH + IGF-1 for 24 hours per dose. The Nass 2008 trial showed 1.6 kg fat-free mass gain over 12 months in older adults — meaningful muscle preservation during a period the control group was losing.
The complication on a cut is MK-677 also bumps appetite, which most cutters do not want. The workaround: run MK-677 on a cut only if you are in a small deficit (250-500 kcal/day) and using the extra hunger to hit protein. For aggressive cuts, pick a GHRH+GHRP instead.
Watch fluid retention in weeks 1-4 and fasting glucose past week 8. HbA1c check at 8 and 12 weeks is non-negotiable.
Cutting protocol: 10-25 mg oral, once daily pre-bed. 12 weeks on, 4 weeks off.
Deep dive: MK-677 Dosing Guide
6. AOD-9604
The C-terminal fragment of GH (residues 177-191), marketed as a fat-specific peptide that preserves lipolysis without the insulin-like side effects of full GH. The human evidence is thinner than vendor marketing suggests — phase II obesity trials did not consistently hit statistical significance on weight-loss endpoints.
Where AOD-9604 is actually useful: as a low-cost adjunct stacked on top of a GHRH+GHRP cut. It is well-tolerated, cheap, and may marginally accelerate localized fat loss (subcutaneous abdominal area in particular). Not a standalone cutting peptide.
Cutting protocol: 300 mcg subcutaneous, AM fasted or pre-workout, 5-6 days per week, stacked on top of tesa+ipa or CJC+ipa. 12 weeks.
Deep dive: Best AOD-9604 Vendors | AOD-9604 Dosing Guide
Top AOD-9604 Vendors
Ranked by price, COA availability, and reputation
7. 5-Amino-1MQ
NNMT (nicotinamide N-methyltransferase) inhibitor. Acts on cellular metabolism by freeing up intracellular NAD+/SAM, which increases metabolic rate and reduces adipose storage in animal models. Human data is limited but mechanistically plausible.
Best framing: an experimental adjunct for the metabolism angle, not a primary cutting tool. Works orally — no injection required, which makes it appealing to users already running an injectable GH stack and wanting a second mechanism via a pill.
Cutting protocol: 50-150 mg oral, once daily AM. 12 weeks.
Deep dive: Best 5-Amino-1MQ Vendors | 5-Amino-1MQ Dosing Guide
Top 5-Amino-1MQ Vendors
Ranked by price, COA availability, and reputation

Cutting Cycle Protocols
Classic bodybuilding cut (12-16 weeks):
- Tesamorelin 2 mg + ipamorelin 100-200 mcg pre-bed, 5 days/week
- Protein at 2.0-2.4 g/kg of lean body mass
- Heavy compound lifts 4x/week
- 500 kcal deficit for weeks 1-8, 300 kcal for weeks 9-16
Budget cut (12 weeks):
- CJC-1295 + ipamorelin 100 mcg each, pre-bed
- Same protein and training as above
- Add AOD-9604 300 mcg AM if budget allows
Stalled cut (add-on for weeks 8+ of a plateau):
- Add cagrilintide 0.25 mg weekly, escalating to 2.4 mg over 4-6 weeks
- Keep the GHRH+GHRP base running
No-needle cut:
- MK-677 15-25 mg daily pre-bed
- HbA1c check at weeks 8 and 12
- Only for small deficits — MK-677's appetite boost makes aggressive cuts impractical
Bloodwork on a Cut
Baseline: IGF-1, fasting glucose, HbA1c, fasting insulin, CMP, lipid panel, testosterone (low calories drop it).
4 weeks: IGF-1, fasting glucose. Target: IGF-1 up 30-60%.
8-12 weeks: Full panel. If HbA1c is up 0.3%+ or glucose up 10 mg/dL, dose-reduce or switch.
Post-cycle: Full panel at 4 weeks off. Testosterone often dips during an aggressive cut; monitor free testosterone and SHBG.
How to Choose
Classic bodybuilding cut, budget not tight — tesamorelin + ipamorelin blend.
First cut, budget matters — CJC-1295 + ipamorelin blend.
Already running a GH stack, fat loss has stalled — add cagrilintide.
No needles — MK-677.
Advanced stack, already running GHRH+GHRP — add AOD-9604 (cheap adjunct) or 5-amino-1MQ (oral metabolism layer).
For the fat-loss-specific ranking (not cutting-specific), see Best Peptides for Fat Loss.
Frequently Asked Questions
What's the difference between a cutting peptide and a weight loss peptide?
A cutting peptide is evaluated by its fat-to-lean loss ratio, not just total weight on the scale. Pure GLP-1 agonists burn 20-25% lean mass during weight loss, which is fine for someone losing 50+ pounds but terrible for a lifter cutting from 18% body fat to 10%. Cutting peptides preserve lean mass because they target fat specifically or shift the body-composition ratio through GH/IGF-1 or amylin signaling.
Can I run tesamorelin + ipamorelin during a cut without losing strength?
Yes — this is exactly what the stack is designed for. Tesamorelin's phase III data shows reduced visceral fat with preserved or increased muscle cross-sectional area. Strength should hold or modestly improve across a 12-week cut if you hit protein and lift heavy.
Is AOD-9604 actually effective?
The human evidence is thinner than marketing claims. Phase II trials showed modest weight loss that did not always reach statistical significance. Mechanistically it is the C-terminal fragment of GH, supposed to preserve lipolytic activity without insulin-like side effects. Works better as an adjunct to a GHRH+GHRP stack than standalone.
Should I stack a GLP-1 on top of a GHRH+GHRP during a cut?
Yes, if you accept the cost and bloodwork cadence. GLP-1 drives fat loss through appetite suppression; GHRH+GHRP drives lean mass preservation. Mechanisms are independent and synergistic. Typical combo: semaglutide or tirzepatide weekly + tesa+ipa pre-bed 5 days per week.
How long should a cutting cycle run?
12-16 weeks for peptide-based cuts. Short enough to avoid GH receptor desensitization, long enough for meaningful body-composition change. Cycle off 4-8 weeks after any GH peptide protocol.
Do these peptides work without resistance training?
Worse. All of these work best paired with heavy lifting 3-4x/week. The peptide provides the anabolic signal; resistance training is the anti-catabolic signal. Without lifting you will still lose fat but not preserve strength or muscle mass.
References
| # |
Citation |
PMID |
| 1 |
Falutz J, et al. Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation. J Clin Endocrinol Metab. 2010;95(9):4291-4304. |
20101189 |
| 2 |
Adrian S, et al. Tesamorelin decreases muscle fat and increases muscle area in adults with HIV. J Frailty Aging. 2019;8(3):154-159. |
31237318 |
| 3 |
Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients. JAMA. 2014;312(4):380-389. |
25038357 |
| 4 |
Bowers CY, et al. GH-releasing peptide acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990;70(4):975-982. |
2108187 |
| 5 |
Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805. |
16352683 |
| 6 |
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. |
9849822 |
| 7 |
Nass R, et al. Effects of an oral ghrelin mimetic on body composition in healthy older adults. Ann Intern Med. 2008;149(9):601-611. |
18981485 |
| 8 |
Garvey WT, et al. Cagrilintide and Semaglutide in Adults with Overweight or Obesity (REDEFINE 1). N Engl J Med. 2025. |
40544432 |